BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 2275087)

  • 21. Lack of efficacy of triclabendazole against Fasciola hepatica is present on sheep farms in three regions of England, and Wales.
    Kamaludeen J; Graham-Brown J; Stephens N; Miller J; Howell A; Beesley NJ; Hodgkinson J; Learmount J; Williams D
    Vet Rec; 2019 Apr; 184(16):502. PubMed ID: 30824600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of diamphenethide on Fasciola hepatica at different stages of development.
    Kendall SB; Parfitt JW
    Res Vet Sci; 1973 Jul; 15(1):37-40. PubMed ID: 4778488
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative kinetics of serological and coproantigen ELISA and faecal egg count in cattle experimentally infected with Fasciola hepatica and following treatment with triclabendazole.
    Brockwell YM; Spithill TW; Anderson GR; Grillo V; Sangster NC
    Vet Parasitol; 2013 Sep; 196(3-4):417-26. PubMed ID: 23643623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones.
    Hodgkinson JE; Cwiklinski K; Beesley N; Hartley C; Allen K; Williams DJL
    Parasit Vectors; 2018 Jun; 11(1):363. PubMed ID: 29941045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Usefulness of the preparation Fasinex (triclabendazole, Ciba-Geigy) for the control of fascioliasis in sheep].
    Ramisz A; Urban E; Balicka-Laurans A
    Wiad Parazytol; 1986; 32(1):93-8. PubMed ID: 3705590
    [No Abstract]   [Full Text] [Related]  

  • 26. Increase of carboxylesterase activity in Fasciola hepatica recovered from triclabendazole treated sheep.
    Scarcella S; Miranda-Miranda E; Cossío-Bayúgar R; Ceballos L; Fernandez V; Solana H
    Mol Biochem Parasitol; 2012 Oct; 185(2):151-3. PubMed ID: 22814337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthelmintic resistance: potential benefits of 'over-diagnosis'.
    Sargison ND; Scott PR
    Vet Rec; 2011 Jun; 168(24):646-7. PubMed ID: 21685422
    [No Abstract]   [Full Text] [Related]  

  • 28. [Advances in the prevention of fascioliasis].
    Boray JC
    Schweiz Arch Tierheilkd; 1971 Jul; 113(7):361-86. PubMed ID: 5093115
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of the effective dose of an experimental intramuscular formulation against immature and adult Fasciola hepatica in sheep.
    Ibarra-Velarde F; Vera-Montenegro Y; Flores-Ramos M; Cantó-Alarcon GJ; Hernández-Campos A; Alcala-Canto Y; Castillo R
    Vet Parasitol; 2018 Aug; 260():38-44. PubMed ID: 30197011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of albendazole against Fasciola hepatica in sheep.
    Johns DR; Dickeson SJ
    Aust Vet J; 1979 Sep; 55(9):431-2. PubMed ID: 543835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Raising the bar on reporting 'triclabendazole resistance'.
    Fairweather I
    Vet Rec; 2011 May; 168(19):514-5. PubMed ID: 21571852
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficiency comparison of experimental fosfatriclaben with three commercial fasciolicides in experimentally infected sheep.
    Arias-García R; Vera-Montenegro Y; Flores-Ramos M; Castillo R; Hernández-Campos A; Ibarra-Velarde F
    Parasitol Res; 2020 Aug; 119(8):2687-2693. PubMed ID: 32514648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of diamphenethide (Coriban) in sheep naturally invaded by Fasciola hepatica].
    Corba J; Hovorka J; Popovic S
    Vet Med (Praha); 1973 Jun; 18(6):365-70. PubMed ID: 4199841
    [No Abstract]   [Full Text] [Related]  

  • 34. Current Threat of Triclabendazole Resistance in Fasciola hepatica.
    Kelley JM; Elliott TP; Beddoe T; Anderson G; Skuce P; Spithill TW
    Trends Parasitol; 2016 Jun; 32(6):458-469. PubMed ID: 27049013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Examination of new anti-fasciola agents. I. Efficacy and toxicity of rafoxanide in sheep, artificially infected with Fasciola hepatica and F. gigantica].
    Boray JC; Wolff K; Trepp HC
    Schweiz Arch Tierheilkd; 1973 Aug; 115(8):367-71. PubMed ID: 4732459
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of a single oral dose of oxfendazole against Fasciola hepatica in naturally infected sheep.
    Gomez-Puerta LA; Gavidia C; Lopez-Urbina MT; Garcia HH; Gonzalez AE;
    Am J Trop Med Hyg; 2012 Mar; 86(3):486-8. PubMed ID: 22403323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficiency of diamphenethide in controlling natural infestations of Fasciola hepatica in lambs.
    Over HJ; Gaasenbeek CP; Pekelder JJ; van Tiggele LJ
    Tijdschr Diergeneeskd; 1978 Jan; 103(2):129-39. PubMed ID: 24284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On farm evaluation of the coproantigen ELISA and coproantigen reduction test in Scottish sheep naturally infected with Fasciola hepatica.
    Gordon DK; Zadoks RN; Stevenson H; Sargison ND; Skuce PJ
    Vet Parasitol; 2012 Jul; 187(3-4):436-44. PubMed ID: 22421492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prophylaxis of ovine fascioliasis by the strategic use of rafoxanide.
    Armour J; Corba J; Bruce RG
    Vet Rec; 1973 Jan; 92(4):83-9. PubMed ID: 4693386
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of nitroxynil on the survival, growth and morphology of Fasciola hepatica in sheep.
    Stammers BM
    Res Vet Sci; 1976 Mar; 20(2):174-9. PubMed ID: 1265355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.